Company intelligence / Profile preview

Daiso

Ownership: Private
Employees: ~720
Development stage: Commercial

Overview

Daiso Chemical manufactures and supplies high-purity chromatographic-grade silica gel under the DAISOGEL brand, widely used in pharmaceutical research and manufacturing—especially for analytical/preparative separations including peptides and proteins. The company also distributes raw materials essential to the chemical, pharmaceutical, cosmetic, electronics, and related industries globally. It does not itself conduct clinical trials or develop drugs but enables these activities through its products.

Modalities: Chromatography media (silica gel for peptide/protein purification)Raw materials for pharmaceuticals and cosmeticsNo direct therapeutic product development; supports modalities such as Peptides, Proteins via purification products
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Daiso.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daiso.

Explore the full profile